GS is not a name you see very often down here in the penny dreadfuls, I think the one you can be certain of is that any buying they do is not passive, it will have an active view/call behind it. However, given our size and the huge value on offer in the market at the moment, it would make sense to me if it were part of a wider call by them in to late stage pharma. If I had more cash I think I would be pretty happy to deploy it in to a basket of listed pharma developers with funded Phase III assets, over the medium term the outcomes are completely uncorrelated to the markets and you are buying those risks at essential systemic crisis level lows.
IXC Price at posting:
46.5¢ Sentiment: Buy Disclosure: Held
